NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

Core Insights - NeuroOne Medical Technologies Corporation announced that Clara, an early patient treated with the OneRF Ablation System, has surpassed one year seizure-free, significantly improving her quality of life [1][2] - The OneRF Ablation System is the first FDA 510(k)-cleared device that utilizes the same sEEG electrode for both diagnostic and therapeutic applications, demonstrating seizure reduction or freedom for most patients treated [3] - The company plans to leverage the OneRF technology for additional applications, including the OneRF Trigeminal Nerve Ablation System for facial pain, with a 510(k) submission filed in April 2025 [4] Company Overview - NeuroOne Medical Technologies Corporation focuses on developing minimally invasive and high-definition solutions for various neurological disorders, including epilepsy, Parkinson's disease, and chronic pain, aiming to improve patient outcomes and reduce procedural costs [5] - The company is exploring potential applications in other areas such as depression, mood disorders, and artificial intelligence [5]